The Tobacco Control Capacity Programme is a £3.4 million programme of training and research funded by Research Councils UK as part of the Global Challenges Research Fund. The overall aim of the programme is to improve research capacity in low- and middle-income countries (LMICs) to conduct high-quality studies that will generate evidence on how to
- Published in Non-Communicable Disease, Our Work
No Comments
The TB and Tobacco project aims to investigate ways in which interventions designed to encourage people to stop smoking can be integrated into tuberculosis (TB) control programmes. Its ultimate goal is to improve the health and longevity of patients suffering from TB, as well as decreasing the number of people who suffer from tobacco-related
- Published in Non-Communicable Disease, Our Work
The overall long-term aim of this research programme is to improve health outcomes and quality of life for people with depression and tuberculosis in South Asia. This study is aimed carring out the preliminary work for a future trial to evaluate depression care integrated with tuberculosis services. The specific objectives are: To understand the
- Published in Non-Communicable Disease, Our Work
This project aimed to develop and evaluate a service delivery model for the delivery of quality care to patients of cardiovascular diseases (CVDs) and diabetes at the Upazila Health Complexes and other primary health care (PHC) facilities. Specific objectives included: establishing a systematic screening and care process to enhance early diagnosis of CVD and
- Published in Non-Communicable Disease, Our Work
Evaluation of Tobacco Dependence Measures of Smokeless Tobacco (ST) users in Bangladesh was a study supported by the University of York, UK. . It was an 18-month project that aimed to evaluate psychometric properties of the Oklahoma Scale of Smokeless Tobacco Dependence among Bangladeshi smokeless tobacco users, and to identify underlying constructs and processes
- Published in Non-Communicable Disease, Our Work
This study aims to develop an acceptable and feasible psychosocial support (PSS) package that will be ready to embed within the existing National TB Control Programme (NTP) service delivery system in Bangladesh. The existing service delivery system does not include any screening for mental health problems among MDR TB patients or psychosocial counselling for
- Published in Non-Communicable Disease, Our Work
Second-hand smoke (SHS) exposure costs 800,000 lives a year. Children in developing countries are worst affected as smoke-free laws are only partially implemented, and private homes and cars remain a key source of SHS exposure. Children Learning About Second-hand Smoking (CLASS-III) is an ongoing project of ARK Foundation in collaboration with University of York.
- Published in Non-Communicable Disease, Our Work
Children Learning About Second-hand Smoke (CLASS-II) was a two-arm pilot cluster randomised controlled trial funded by the Medical Research Council, UK. The project primarily aimed to establish the effectiveness of a school-based intervention, ‘Smoke Free Homes’ , in reducing exposure of school children to second hand smoke. Its effect on frequency and severity of
- Published in Non-Communicable Disease, Our Work
Quit 4 TB Trial project aims to assess in people with TB who smoke daily and check the effectiveness and cost effectiveness of mTB-Tobacco in achieving continuous abstinence for at least six months and also assess the effectiveness and cost effectiveness of mTB-Tobacco in enhancing TB treatment adherence and improving clinical outcomes. We will conduct
- Published in Non-Communicable Disease, Our Work
Children Learning About Second-hand Smoke (CLASS-III) is an ongoing multinational cRCT project of ARK Foundation in collaboration with the University of York, United Kingdom. The project aims to assess the effectiveness and cost-effectiveness of school-based Smoke-Free Intervention (SFI) in reducing children’s exposure to second-hand smoking (SHS) and the frequency and severity of respiratory symptoms. The
- Published in Featured, Non-Communicable Disease, Our Work